Cytomegalovirus resistance to antiviral therapies

American Journal of Health-System Pharmacy

Volumn 53, Issue 8 SUPPL. 2, 1996, Pages

  Drew, W Lawrence ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIDOFOVIR; FOSCARNET; GANCICLOVIR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIVIRAL ACTIVITY; CLINICAL TRIAL; CONFERENCE PAPER; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG SENSITIVITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION MAPPING; RETINITIS; TREATMENT OUTCOME;

EID: 0029912314     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Fraser-Smith EB. Test for resistance of human cytomegalovirus to ganciclovir. Palo Alto, CA: Syntex Research, Institution of Agriscience, Department of Antimicrobial Research, Document No. RS-21592 CL 4617. 1988.
2. Erice A, Chou S, Biron KK et al. Progressive disease due to ganciclovir-resistant cytomegalovirus in immunocompromised patients. N Engl J Med. 1989; 320:289-93.
3. Plotkin SA, Drew WL, Felsenstein D et al. Sensitivity of clinical isolates of human cytomegalovirus to 9-(dihydroxy-2-propoxymethyl)guanine. J Infect Dis. 1985; 152:833-4.
4. Drew WL, Miner RC, Busch DF, et al. Prevalence of resistance in patients receiving ganciclovir for serious cytomegalovirus infection. J Infect Dis. 1991; 163:716-9.
5. Tseng LF. Rapid and simple antiviral sensitivity testing of cytomegalovirus (CMV). Paper presented at 92nd General Meeting of the American Society for Microbiology. New Orleans, LA: 1992.
6. Pepin J, Simon F, Dussault A et al. Rapid determination of human cytomegalovirus susceptibility to ganciclovir directly from clinical specimen primocultures. J Clin Microbiol. 1992; 30:2917.
7. Boivin G, Erice A, Crane DD et al. Ganciclovir susceptibilities of cytomegalovirus (CMV) isolates from solid organ transplant recipients with CMV viremia after antiviral prophylaxis. J Infect Dis. 1993; 168:332-5.
8. Slavin MA, Bindra RR, Gleaves CA et al. Ganciclovir sensitivity of cytomegalovirus at diagnosis and during treatment of cytomegalovirus pneumonia in marrow transplant recipients. Antimicrob Agents Chemother. 1993; 37:1360-3.
9. Spector S, Busch D, Follansbee S et al. Pharmacokinetic, safety, and antiviral profiles of oral ganciclovir in persons infected with human immunodeficiency virus: a phase I/II study. J Infect Dis. 1995; 171:1431-7.
10. Buhles W, Drew WL, Miner RC for the Syntex Cooperative Oral Ganciclovir Study Group. Cytomegalovirus (CMV) resistance rates following treatment with IV and oral ganciclovir (GCV). Paper presented at 34th Interscience Conference on Antimicrobial Agents and Chemotherapy. Orlando, FL: 1994 Oct 4-7.
11. Sullivan V, Coen DM. Isolation of foscarnet-resistant human cytomegalovirus patterns of resistance and sensitivity to other antiviral drugs. J Infect Dis. 1991; 164:781-4.
12. Drew WL, Miner RC, Saleh E. Antiviral susceptibility testing of cytomegalovirus: criteria for detecting resistance to antivirals. Clin and Diag Virol. 1993; 1:179-85.
13. Tatarowicz WA, Lurain NS, Thompson KD. A ganciclovir-resistant clinical isolate of human cytomegalovirus exhibiting cross-resistance to other DNA polymerase inhibitors. J Infect Dis. 1992; 166:904-7.
14. Knox KK, Drobyski WR, Carrigan DR. Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient. Lancet. 1991; 337:1292-3.
15. Leport C, Puget S, Pepin JM et al. Meningoradiculoneuritis due to acyclovir-resistant varicella-zoster virus in a patient with AIDS. J Infect Dis. 1993; 168:1330-1.
16. Flores-Aguilar M, Kupperman BD, Quiceno JI et al. Pathophysiology and treatment of clinically resistant cytomegalovirus retinitis. Ophthalmology. 1993; 100:1022-30.
17. Smith RL, Jiles RE, Benbatoul KD et al. Molecular characterization of foscarnet resistant phenotypes of viral isolates from HCMV retinitis patients. Abstract presented at 19th International Herpesvirus Workshop. Vancouver, BC: 1994 Aug.